GSK Seeks Dismissal Of 27 Zofran Birth Defect MDL Cases Involving Generics
(Brief available. Document #28-161020-008B.)
Zofran brand ondansetron is approved to treat nausea and vomiting in patients after surgery or after cancer chemotherapy. Plaintiffs allege that GSK promoted Zofran to treat morning sickness from pregnancy and that the drug...
To view the full article, register now.